The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Capecitabine API Market Research Report 2025

Global Capecitabine API Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1601287

No of Pages : 103

Synopsis
It is an anti-tumor API, CAS No: 154361-50-9, molecular formula: C15H22FN3O6.
The global Capecitabine API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Capecitabine API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Capecitabine API.
Report Scope
The Capecitabine API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Capecitabine API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Capecitabine API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Apotex Pharmachem
Shilpa Medicare Limited
Dr. Reddy's Laboratories
Scion Pharm Taiwan
Gland Chemicals
Acebright
Qilu Pharmaceutial
Aarti Industries
Cipla
Haizhou Pharma
Xinxiang Tuoxin Pharmaceutical
Xinxiang Best Pharmaceutical
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Capecitabine Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Capecitabine API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Capecitabine API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Capecitabine API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index
1 Capecitabine API Market Overview
1.1 Product Definition
1.2 Capecitabine API Segment by Type
1.2.1 Global Capecitabine API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Capecitabine API Segment by Application
1.3.1 Global Capecitabine API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Capecitabine Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Capecitabine API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Capecitabine API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Capecitabine API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Capecitabine API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Capecitabine API Production Market Share by Manufacturers (2019-2024)
2.2 Global Capecitabine API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Capecitabine API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Capecitabine API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Capecitabine API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Capecitabine API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Capecitabine API, Product Offered and Application
2.8 Global Key Manufacturers of Capecitabine API, Date of Enter into This Industry
2.9 Capecitabine API Market Competitive Situation and Trends
2.9.1 Capecitabine API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Capecitabine API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Capecitabine API Production by Region
3.1 Global Capecitabine API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Capecitabine API Production Value by Region (2019-2030)
3.2.1 Global Capecitabine API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Capecitabine API by Region (2025-2030)
3.3 Global Capecitabine API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Capecitabine API Production by Region (2019-2030)
3.4.1 Global Capecitabine API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Capecitabine API by Region (2025-2030)
3.5 Global Capecitabine API Market Price Analysis by Region (2019-2024)
3.6 Global Capecitabine API Production and Value, Year-over-Year Growth
3.6.1 North America Capecitabine API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Capecitabine API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Capecitabine API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Capecitabine API Production Value Estimates and Forecasts (2019-2030)
4 Capecitabine API Consumption by Region
4.1 Global Capecitabine API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Capecitabine API Consumption by Region (2019-2030)
4.2.1 Global Capecitabine API Consumption by Region (2019-2024)
4.2.2 Global Capecitabine API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Capecitabine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Capecitabine API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Capecitabine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Capecitabine API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Capecitabine API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Capecitabine API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Capecitabine API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Capecitabine API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Capecitabine API Production by Type (2019-2030)
5.1.1 Global Capecitabine API Production by Type (2019-2024)
5.1.2 Global Capecitabine API Production by Type (2025-2030)
5.1.3 Global Capecitabine API Production Market Share by Type (2019-2030)
5.2 Global Capecitabine API Production Value by Type (2019-2030)
5.2.1 Global Capecitabine API Production Value by Type (2019-2024)
5.2.2 Global Capecitabine API Production Value by Type (2025-2030)
5.2.3 Global Capecitabine API Production Value Market Share by Type (2019-2030)
5.3 Global Capecitabine API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Capecitabine API Production by Application (2019-2030)
6.1.1 Global Capecitabine API Production by Application (2019-2024)
6.1.2 Global Capecitabine API Production by Application (2025-2030)
6.1.3 Global Capecitabine API Production Market Share by Application (2019-2030)
6.2 Global Capecitabine API Production Value by Application (2019-2030)
6.2.1 Global Capecitabine API Production Value by Application (2019-2024)
6.2.2 Global Capecitabine API Production Value by Application (2025-2030)
6.2.3 Global Capecitabine API Production Value Market Share by Application (2019-2030)
6.3 Global Capecitabine API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Apotex Pharmachem
7.1.1 Apotex Pharmachem Capecitabine API Corporation Information
7.1.2 Apotex Pharmachem Capecitabine API Product Portfolio
7.1.3 Apotex Pharmachem Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Apotex Pharmachem Main Business and Markets Served
7.1.5 Apotex Pharmachem Recent Developments/Updates
7.2 Shilpa Medicare Limited
7.2.1 Shilpa Medicare Limited Capecitabine API Corporation Information
7.2.2 Shilpa Medicare Limited Capecitabine API Product Portfolio
7.2.3 Shilpa Medicare Limited Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Shilpa Medicare Limited Main Business and Markets Served
7.2.5 Shilpa Medicare Limited Recent Developments/Updates
7.3 Dr. Reddy's Laboratories
7.3.1 Dr. Reddy's Laboratories Capecitabine API Corporation Information
7.3.2 Dr. Reddy's Laboratories Capecitabine API Product Portfolio
7.3.3 Dr. Reddy's Laboratories Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.4 Scion Pharm Taiwan
7.4.1 Scion Pharm Taiwan Capecitabine API Corporation Information
7.4.2 Scion Pharm Taiwan Capecitabine API Product Portfolio
7.4.3 Scion Pharm Taiwan Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Scion Pharm Taiwan Main Business and Markets Served
7.4.5 Scion Pharm Taiwan Recent Developments/Updates
7.5 Gland Chemicals
7.5.1 Gland Chemicals Capecitabine API Corporation Information
7.5.2 Gland Chemicals Capecitabine API Product Portfolio
7.5.3 Gland Chemicals Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Gland Chemicals Main Business and Markets Served
7.5.5 Gland Chemicals Recent Developments/Updates
7.6 Acebright
7.6.1 Acebright Capecitabine API Corporation Information
7.6.2 Acebright Capecitabine API Product Portfolio
7.6.3 Acebright Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Acebright Main Business and Markets Served
7.6.5 Acebright Recent Developments/Updates
7.7 Qilu Pharmaceutial
7.7.1 Qilu Pharmaceutial Capecitabine API Corporation Information
7.7.2 Qilu Pharmaceutial Capecitabine API Product Portfolio
7.7.3 Qilu Pharmaceutial Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Qilu Pharmaceutial Main Business and Markets Served
7.7.5 Qilu Pharmaceutial Recent Developments/Updates
7.8 Aarti Industries
7.8.1 Aarti Industries Capecitabine API Corporation Information
7.8.2 Aarti Industries Capecitabine API Product Portfolio
7.8.3 Aarti Industries Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Aarti Industries Main Business and Markets Served
7.7.5 Aarti Industries Recent Developments/Updates
7.9 Cipla
7.9.1 Cipla Capecitabine API Corporation Information
7.9.2 Cipla Capecitabine API Product Portfolio
7.9.3 Cipla Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Cipla Main Business and Markets Served
7.9.5 Cipla Recent Developments/Updates
7.10 Haizhou Pharma
7.10.1 Haizhou Pharma Capecitabine API Corporation Information
7.10.2 Haizhou Pharma Capecitabine API Product Portfolio
7.10.3 Haizhou Pharma Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Haizhou Pharma Main Business and Markets Served
7.10.5 Haizhou Pharma Recent Developments/Updates
7.11 Xinxiang Tuoxin Pharmaceutical
7.11.1 Xinxiang Tuoxin Pharmaceutical Capecitabine API Corporation Information
7.11.2 Xinxiang Tuoxin Pharmaceutical Capecitabine API Product Portfolio
7.11.3 Xinxiang Tuoxin Pharmaceutical Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Xinxiang Tuoxin Pharmaceutical Main Business and Markets Served
7.11.5 Xinxiang Tuoxin Pharmaceutical Recent Developments/Updates
7.12 Xinxiang Best Pharmaceutical
7.12.1 Xinxiang Best Pharmaceutical Capecitabine API Corporation Information
7.12.2 Xinxiang Best Pharmaceutical Capecitabine API Product Portfolio
7.12.3 Xinxiang Best Pharmaceutical Capecitabine API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Xinxiang Best Pharmaceutical Main Business and Markets Served
7.12.5 Xinxiang Best Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Capecitabine API Industry Chain Analysis
8.2 Capecitabine API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Capecitabine API Production Mode & Process
8.4 Capecitabine API Sales and Marketing
8.4.1 Capecitabine API Sales Channels
8.4.2 Capecitabine API Distributors
8.5 Capecitabine API Customers
9 Capecitabine API Market Dynamics
9.1 Capecitabine API Industry Trends
9.2 Capecitabine API Market Drivers
9.3 Capecitabine API Market Challenges
9.4 Capecitabine API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’